Information for participants and those interested in participating
The Harvard Aging Brain Study (HABS) is an observational study that aims to find out whether the changes that a doctor sometimes sees on a brain scan are related to early memory changes that occur in older healthy adults.
The Harvard Aging Brain Study has published over 150 manuscripts contributing to the field of Alzheimer’s Disease research in major journals such as Nature, Alzheimer’s & Dementia, Neurology, and more. We invite researchers of diverse fields to expand and explore data used in this project, as both imaging and neuropsychological data are publicly available upon […]
Despite COVID-19, we at the Harvard Aging Brain Study are still hard at work!
Learn more about the team at the Harvard Aging Brain Study
Explore affiliated Alzheimer’s disease research centers, additional organizations, more studies, and useful resources.
Information about HABS-affiliated studies including ARMADA, AWARE, MOMENT, and SONNET
The importance of memory complaints in the early detection of Alzheimer’s Disease, with Dr. Rebecca Amariglio, PhD. Also includes The Mental Note – Issue 10
The intersection of music and memory and its impacts on everyday life with Dr. Edmarie Guzmán-Vélez. Also includes The Mental Note – Issue 9
What your blood samples can teach us about Alzheimer’s, with Dr. Hyun-Sik Yang, MD
The importance of memory complaints in the early detection of Alzheimer’s Disease, with Dr. Rebecca Amariglio, PhD. Also includes The Mental Note – Issue 10
MedicalResearch.com Interview with Dr Nancy Donovan
MedicalResearch.com: What is the background for this study? Response: Prior research has shown that widowed older adults are more likely to experience cognitive decline than those who are married. However, there have been no prior studies of widowhood as a risk factor for cognitive decline due to Alzheimer’s disease, the most common cause of severe […]
The search for an antibody that could strike at the core of the disease
In a first-of-its kind trial, researchers are testing a drug they hope will stop Alzheimer’s disease in its tracks before damage begins. Neurologist Reisa Sperling is one of the country’s top medical minds and for her, Alzheimer’s is very personal. “My grandfather developed symptoms when I was applying to medical school, and it definitely influenced […]
#WomeninSCDmonth =>Spotlight on Dr Rebecca Amariglio @rivkae, Dr Talia Robinson and Dr Catherine Munro @cmunrophd from @BrighamWomens
@HarvardAging An outstanding group of women defining the field of SCD. Please see below some of their AMAZING WORK!
📢 There are openings for this T32 postdoc training in Alzheimer’s Disease Research @MGHMartinos: “Program to Enrich Translation and Multimodal Research in Alzheimer’s Disease (PET/MR in ADRD)” 👍🏼 Check it out! Must be U.S. citizen or permanent resident
https://pricelab.martinos.org/t32-adrd/
We reached the #AAIC23 abstract deadline! And still alive! Amsterdam here we come. 🧡 Celebrating #postdoclife @HarvardAging @Schultz_SA @ChristophPhD @mabelseto1 @WendyYau01 @RoreBole @GagGeo
